TBPH — Theravance Biopharma Share News
0.000.00%
Last trade - 00:00- $857.84m
- $495.97m
- $107.46m
Brief: Theravance Biopharma Q1 Operating Income USD -14.434 Million
Theravance Biopharma Inc expected to post a loss of 23 cents a share - Earnings Preview
Theravance Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Theravance Biopharma Q4 Operating Income USD -9.2 Million
Theravance Biopharma Inc expected to post a loss of 21 cents a share - Earnings Preview
Theravance Biopharma Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Theravance Biopharma Q3 Operating Income USD -10.837 Million
Theravance Biopharma Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Theravance Announces Publication of YUPELRI® (revefenacin) Area
Theravance Biopharma Inc reports results for the quarter ended in June - Earnings Summary
Brief: Theravance Biopharma Q2 Operating Income USD -15.705 Million
Theravance Biopharma Inc expected to post a loss of 21 cents a share - Earnings Preview
Theravance Biopharma Inc reports results for the quarter ended in March - Earnings Summary
Brief: Theravance Biopharma Q1 Operating Income USD -11.207 Million
Theravance Biopharma Inc expected to post a loss of 25 cents a share - Earnings Preview
Theravance Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Theravance Biopharma Inc expected to post a loss of 15 cents a share - Earnings Preview
Brief: Theravance Biopharma and Mylan Enter Into Settlement Agreement With Orbicular Pharmaceutical Technologies
U.S. STOCKS ON THE MOVE-CVS Health, Peloton, Eli Lilly